Almirall S.A Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: €10.22 High: €10.34
on August 8, 2025

52 Week Range

Low: €8.03 High: €11.50
on December 30, 2024
on July 25, 2025

All-Time High: €19.09 on December 28, 2015

Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights

Key Statistics

Market Cap i €2.2B
EPS i 0.10
P/E Ratio (TTM) i 102.60
Forward P/E i 22.30
P/B Ratio i 1.51
PEG Ratio i 22.30
Div. Yield i 1.67%
ROE i 1.45%
Beta i 0.317
Debt to Equity i 26.47

Financial Highlights

Profitability

Gross Margin i 91.07%
Operating Margin i 3.22%
Profit Margin i 2.02%

Returns and Earnings

Return on Assets (TTM) i 1.56%
Return on Equity (TTM) i 1.45%
EBITDA i €221.8M
Net Income (TTM) i €21.3M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i €4.94
Quarterly Revenue Growth (YoY) i 10.30%
Quarterly Earnings Growth (YoY) i -37.70%

Dividend Information

Last 12-Month Dividend i €0.18
Current Dividend Yield i 1.67%
3-Year Average Dividend Yield i 1.97%
3-Year Average Annual Dividend i €0.18
3-Year Total Dividends i €0.54
Ex-Dividend Date i May 15, 2025

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Almirall S.A ALM 2.20B Large-cap-3.21%-4.12%0.20%13.15%22.20%14.03%4.28%7.11%
Laboratorios ROVI 2.72B Large-cap-2.03%-3.37%3.41%-4.32%-17.03%-32.16%1.36%86.38%
Faes Farma S.A FAE 1.31B Large-cap-3.21%-5.80%-0.24%15.30%20.23%19.89%7.11%21.97%
Laboratorio Reig RJF 240.10M Mid-cap2.03%1.68%1.00%14.83%17.51%9.49%8.70%-20.84%
Labiana Health S.A LAB 28.16M Small-cap4.32%15.57%19.14%33.10%31.29%22.58%6,233.33%1,051.52%
Grifols, S.A GRF 7.93B Large-cap-2.06%22.50%57.28%54.08%35.84%46.52%-6.61%-47.55%

Ownership & Short Interest

Insider Ownership i 64.93%
Institutional Ownership i 18.20%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 134K
Average 90-Day Volume i 102K

Almirall S.A Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Almirall S.A would have performed over time.

If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Almirall S.A reached a high of €11.50 (on July 25, 2025) and a low of €8.03 (on December 30, 2024).
Curious about Almirall S.A's size and valuation? Its market capitalization stands at 2.20B. When it comes to valuation, the P/E ratio (trailing twelve months) is 102.60, and the forward P/E (looking ahead) is 22.30.
Yes, Almirall S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.67%, and the company has paid an average of €0.18 per share annually over the past 3 years.

When looking at Almirall S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
Laboratorios
ROVI
2.72BHealthcareDrug Manufacturers - Specialty & Generic-32.16%1.36%
Faes Farma S.A
FAE
1.31BHealthcareDrug Manufacturers - Specialty & Generic19.89%7.11%
Laboratorio Reig
RJF
240.10MHealthcareDrug Manufacturers - Specialty & Generic9.49%8.70%
Labiana Health S.A
LAB
28.16MHealthcareDrug Manufacturers - Specialty & Generic22.58%6,233.33%
Grifols, S.A
GRF
7.93BHealthcareDrug Manufacturers - General46.52%-6.61%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Almirall S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.45%, the Debt to Equity ratio from the most recent quarter is 26.47, and its Gross Profit Margin stands at 91.07%.
Looking at Almirall S.A's growth, its revenue over the trailing twelve months (TTM) was €1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.30%, and quarterly earnings saw a YoY growth of -37.70%.
Wondering who owns Almirall S.A stock? Company insiders (like executives and directors) hold about 64.93% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 18.20%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.